Medicenna Therapeutics Corp. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Medicenna Therapeutics Corp. (MDNAF) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of 1.47 CAD/shares for the 12-month period ending 2022-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2023-06-27
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2022-03-31 | 1.47 CAD/shares 20-F · filed 2023-06-27 |
| 2021-03-31 | 1.29 CAD/shares 20-F · filed 2023-06-27 |